Moonlight Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 9

Moonlight Therapeutics General Information

Description

Developer of intradermal therapy designed to transform the lives of people with food allergies. The company offers a small, painless intradermal stamp providing at-home administration with effective desensitization, enabling individuals with peanut allergies to reduce their risk of dangerous allergic reactions and support safer daily living.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3175 Presidential Drive
  • Atlanta, GA 30340
  • United States
+1 (404)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3175 Presidential Drive
  • Atlanta, GA 30340
  • United States
+1 (404)

Moonlight Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Moonlight Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 01-Jul-2025 Completed Pre-Clinical Trials
10. Later Stage VC (Series A) 01-Aug-2024 Completed Pre-Clinical Trials
9. Grant 01-Jan-2023 Completed Pre-Clinical Trials
8. Grant 02-Aug-2021 Completed Pre-Clinical Trials
7. Grant 01-Jan-2021 Completed Pre-Clinical Trials
6. Accelerator/Incubator 01-Oct-2020 Completed Pre-Clinical Trials
5. Grant 07-May-2019 Completed Pre-Clinical Trials
4. Grant 01-Apr-2019 Completed Pre-Clinical Trials
3. Grant 01-Jan-2019 $651K Completed Pre-Clinical Trials
2. Grant 12-Oct-2018 $3.3M Completed Pre-Clinical Trials
To view Moonlight Therapeutics’s complete valuation and funding history, request access »

Moonlight Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A-2
Series A-3 1,381,064 $0.000100 $0.32 $0.32 1x $0.32 8.05%
To view Moonlight Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Moonlight Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Moonlight Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
IndieBio Accelerator/Incubator Minority
SOSV Venture Capital Minority
AllerFund Ventures Venture Capital Minority
Georgia Research Alliance Not-For-Profit Venture Capital Minority
Portal Innovations Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Moonlight Therapeutics FAQs

  • When was Moonlight Therapeutics founded?

    Moonlight Therapeutics was founded in 2017.

  • Where is Moonlight Therapeutics headquartered?

    Moonlight Therapeutics is headquartered in Atlanta, GA.

  • What is the size of Moonlight Therapeutics?

    Moonlight Therapeutics has 6 total employees.

  • What industry is Moonlight Therapeutics in?

    Moonlight Therapeutics’s primary industry is Drug Discovery.

  • Is Moonlight Therapeutics a private or public company?

    Moonlight Therapeutics is a Private company.

  • What is Moonlight Therapeutics’s current revenue?

    The current revenue for Moonlight Therapeutics is .

  • How much funding has Moonlight Therapeutics raised over time?

    Moonlight Therapeutics has raised $2.42M.

  • Who are Moonlight Therapeutics’s investors?

    IndieBio, SOSV, AllerFund Ventures, Georgia Research Alliance, and Portal Innovations are 5 of 9 investors who have invested in Moonlight Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process